Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma ServicesSeptember 27, 2023

FDA 483 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - September 27, 2023

Record Details

This 483 record concerns Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services, with an inspection on September 27, 2023, issued by the FDA District Office — Stoneham, Massachusetts, covering drugs.

Company: Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
Inspection Date: September 27, 2023
Product Type: Drugs
Office: FDA District Office — Stoneham, Massachusetts
People: Erik W. Koester (Investigator)
Samuel J Arsenault
Jane T Christenson
Sean R. Marcsisin (Senior Consumer Safety Officer - Pharmaceutical Quality)

Open in Dashboard

ID · 75c9f173-aa20-48af-801d-0567bd3f361b